MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0090497
Clementia Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹2.12 Cr
▲ 5% YoY
Net profit · FY 2026
₹5.66 Lakh
Net margin 2.7%
EBITDA · FY 2026
₹20.79 Lakh
EBITDA margin 9.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
19
Provident fund records
Directors on board
3
As per MCA filings
About Clementia Pharmaceuticals Private Limited
Data last updated:
Clementia Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2012PTC233594. Its GSTIN is 27AAECC9128L1ZA (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Milind S Tawade and Sudeepto Deepak Nag.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gami Industrial Park, Thane, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹2.12 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹5.66 Lakh (net margin 2.7%) and EBITDA of ₹20.79 Lakh (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
Clementia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0090497). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clementia.co.in.
Company details
CIN U24290MH2012PTC233594
Registration Number 233594
Incorporation Date 20 July 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0090497
Recognitions & Rankings of Clementia Pharmaceuticals
Contact details
Clementia Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is clementia.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No.103 2nd Floor Plot No.C – 39A, Gami Industrial Park Pawane, Thane, Maharashtra, India – 400710
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Clementia Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Clementia Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clementia Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Clementia Pharmaceuticals Private Limited, buy the company report.
Financials of Clementia Pharmaceuticals Private Limited
FY 2025 filings availableClementia Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr (up 5% YoY) for FY 2026.
Revenue · FY 2026
₹2.12 Cr ▲ 5%
Net profit · FY 2026
₹5.66 Lakh margin 2.7%
EBITDA · FY 2026
₹20.79 Lakh margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 5%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 42%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 5% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clementia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clementia Pharmaceuticals Private Limited
Clementia Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milind S Tawade | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
| Sudeepto Deepak Nag | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
| Ganesh Vitthal Shinde | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
Shareholding
The shareholding of Clementia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Clementia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Clementia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clementia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Clementia Pharmaceuticals Private Limited has a workforce of 19 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
19
Active EPFO establishments
1
Employee growth
11.76%
GST
Clementia Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC9128L1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Clementia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clementia Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Anjan Choudhury ceased to be Director on 09 Feb 2016.
AGM
Clementia Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Clementia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Anjan Choudhury ceased to be Director.
Appointed
Ganesh Vitthal Shinde was appointed as Director.
Appointed
Milind S Tawade was appointed as Director.
Appointed
Sudeepto Deepak Nag was appointed as Director.
Incorporation
20 Jul 2012
Clementia Pharmaceuticals Private Limited was registered on 20 Jul 2012 with Roc Mumbai Ii & aged 14 years 3 months as per MCA records.
Frequently asked questions
Clementia Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24290MH2012PTC233594.
Clementia Pharmaceuticals has 3 current directors:
- Milind S Tawade - Director
- Sudeepto Deepak Nag - Director
- Ganesh Vitthal Shinde - Director
The latest financial statements of Clementia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Clementia Pharmaceuticals is 27AAECC9128L1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Clementia Pharmaceuticals is U24290MH2012PTC233594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clementia Pharmaceuticals was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Anjan Choudhury ceased to be Director on 09 Feb 2016. Ganesh Vitthal Shinde was appointed as Director on 20 Jul 2012. Milind S Tawade was appointed as Director on 20 Jul 2012. Clementia Pharmaceuticals has 4 board changes on record in total.
Yes, Clementia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0090497).
Clementia Pharmaceuticals can be reached through the website clementia.co.in. Its registered office is in Thane, Maharashtra, India.
The registered office of Clementia Pharmaceuticals is at Shop No.103 2nd Floor Plot No.C – 39A, Gami Industrial Park Pawane, Thane, Maharashtra, India – 400710.